How Esketamine Works

Depression is a common and serious mental health condition affecting millions worldwide. Despite the availability of various antidepressant medications, many people with depression do not respond to traditional treatments, leaving them with limited options for effective symptom relief. Esketamine, a by-product of the drug ketamine, has been making waves in the field of psychiatry as a potential breakthrough treatment for treatment-resistant depression. If you or someone you love has been struggling with symptoms of depression, you are not alone. Continue reading to learn more about esketamine therapy, how it works, and how you may benefit from this treatment option.

What is esketamine?

Esketamine, or S-ketamine, is a type of medication used in psychiatry to treat patients with treatment-resistant depression (TRD) and major depressive disorder (MDD) in adults. It is a by-product of ketamine, a well-known anesthetic drug used for several years in clinical settings. Esketamine is a nasal spray that works as a rapid-acting antidepressant, and it was approved by the United States Food and Drug Administration (FDA) to treat TRD and MDD in 2019.

How does esketamine work?

It is not yet fully understood how esketamine works to decrease symptoms of depression. However, mental professionals believe it mainly works by targeting the glutamate system in the brain. Glutamate is a neurotransmitter that plays a crucial role in the brain's function and is responsible for mood regulation, learning, and memory. Esketamine binds to glutamate receptors in the brain and blocks N-methyl-D-aspartate (NMDA) receptors. By blocking the NMDA receptors, esketamine reduces the activity of the glutamate system, leading to a decrease in symptoms of depression.

The role of esketamine in psychiatry

In psychiatry, esketamine can also work as an additional therapy with antidepressants in adults with TRD and MDD. It can act as a complementary treatment option to traditional oral antidepressants. Esketamine is not a first-line treatment for depression. It is intended for patients who have not responded to at least two traditional antidepressants over a specific period of time.

Eskatmine is administered as a nasal spray, usually twice a week during the first month of treatment, followed by a once-a-week maintenance dose. The medication is administered in a clinical setting. After a treatment session, patients must remain under observation for at least two hours due to the potential side effects of the medication. They may also have a family member or friend drive them home.

Candidates for esketamine treatment

Mental health professionals and other medical providers often recommend esketamine therapy for individuals diagnosed with treatment-resistant depression. This diagnosis means these patients have not responded well to traditional antidepressant medications. This may include people who have tried multiple antidepressants or therapies without success or have experienced only partial symptom relief from standard treatments. In addition, a psychiatrist may recommend esketamine therapy for those who struggle with suicidal ideation or need rapid relief from their depressive symptoms.

The safety and efficacy of esketamine

Clinical trials have illustrated that esketamine is useful in treating adults suffering from TRD and MDD. For example, in a randomized, double-blind, placebo-controlled study, patients with TRD who received an esketamine nasal spray showed a significant improvement in their depressive symptoms compared to those who received a placebo nasal spray. Another study evaluated the efficacy of esketamine on patients with MDD and found similar results.

As with any medication, esketamine does cause some side effects. They usually occur up to two hours after a treatment session. Common side effects of this treatment option include:

• Dizziness
• Nausea
• Increased blood pressure
• Feeling drowsy or "drunk-like"
• Feeling disconnected from oneself or reality
• Hallucinations
• Headache

In addition, the long-term effects of esketamine use are not yet fully understood its potential impact on cognitive function and memory. As with any medication, it is important to discuss the potential risks and benefits of esketamine use with a qualified psychiatrist before beginning treatment. Esketamine does not work for everyone. Some patients may find that it does not help with their depression symptoms. In this case, they should speak to their psychiatrist if they do not start to feel any improvement.

Do you need depression relief?

Esketamine represents a promising new approach to treating depression, particularly for those who have not responded to traditional antidepressant treatment options. In addition, it offers new hope to those who have struggled to find relief from depression symptoms. As with any medication, weighing the benefits against the risks is important, and working closely with your psychiatrist to determine if esketamine is an appropriate treatment option. Call our office to learn more about esketamine. We can answer any questions or concerns you may have and can schedule you for a consultation. Find relief today and make an appointment.

Future Psych Ketamine Clinics offers esketamine therapy in the Myrtle Beach area. To learn more, visit https://mb.futurepsychsolutions.com or call (843) 788-9718 to schedule an appointment.

Check out what others are saying about our services on Yelp: Esketamine in Myrtle Beach, SC.